198 related articles for article (PubMed ID: 23661264)
1. Novel pathways and molecular targets for the treatment of sarcoma.
Frith AE; Hirbe AC; Van Tine BA
Curr Oncol Rep; 2013 Aug; 15(4):378-85. PubMed ID: 23661264
[TBL] [Abstract][Full Text] [Related]
2. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Nakano K; Takahashi S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
[TBL] [Abstract][Full Text] [Related]
3. New therapeutic targets in soft tissue sarcoma.
Demicco EG; Maki RG; Lev DC; Lazar AJ
Adv Anat Pathol; 2012 May; 19(3):170-80. PubMed ID: 22498582
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets.
Merlini A; Rabino M; Brusco S; Pavese V; Masci D; Sangiolo D; Bironzo P; Scagliotti GV; Novello S; D'Ambrosio L
Expert Opin Ther Targets; 2024; 28(1-2):17-28. PubMed ID: 38234142
[TBL] [Abstract][Full Text] [Related]
5. Advances in sarcoma genomics and new therapeutic targets.
Taylor BS; Barretina J; Maki RG; Antonescu CR; Singer S; Ladanyi M
Nat Rev Cancer; 2011 Jul; 11(8):541-57. PubMed ID: 21753790
[TBL] [Abstract][Full Text] [Related]
6. New targeted therapies in liposarcoma: state of art and future perspectives.
Franza A; Fabbroni C; Pasquali S; Casali PG; Sanfilippo R
Curr Opin Oncol; 2024 Jul; 36(4):291-296. PubMed ID: 38726840
[TBL] [Abstract][Full Text] [Related]
7. Genetic aberrations and molecular biology of cardiac sarcoma.
Urbini M; Astolfi A; Indio V; Nannini M; Pizzi C; Paolisso P; Tarantino G; Pantaleo MA; Saponara M
Ther Adv Med Oncol; 2020; 12():1758835920918492. PubMed ID: 32489430
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies for adult soft tissue sarcoma.
Radaelli S; Stacchiotti S; Casali PG; Gronchi A
Expert Rev Anticancer Ther; 2014 Jun; 14(6):689-704. PubMed ID: 24555529
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for sarcomas.
Forscher C; Mita M; Figlin R
Biologics; 2014; 8():91-105. PubMed ID: 24669185
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expression combined with in situ proximity ligation assay.
Ouladan S; Trautmann M; Orouji E; Hartmann W; Huss S; Büttner R; Wardelmann E
Int J Oncol; 2015; 46(6):2595-605. PubMed ID: 25901508
[TBL] [Abstract][Full Text] [Related]
11. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
Nielsen TO; Poulin NM; Ladanyi M
Cancer Discov; 2015 Feb; 5(2):124-34. PubMed ID: 25614489
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS.
Stacchiotti S; Marrari A; Dei Tos AP; Casali PG
Hematol Oncol Clin North Am; 2013 Oct; 27(5):1049-61. PubMed ID: 24093175
[TBL] [Abstract][Full Text] [Related]
13. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics.
Doyle LA; Vivero M; Fletcher CD; Mertens F; Hornick JL
Mod Pathol; 2014 Mar; 27(3):390-5. PubMed ID: 24030747
[TBL] [Abstract][Full Text] [Related]
14. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
Ryan CW; Desai J
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
[TBL] [Abstract][Full Text] [Related]
15. Revisiting 'Hallmarks of Cancer' In Sarcomas.
Honoki K; Tsujiuchi T; Kishi S; Kuniyasu H
J Cancer; 2024; 15(7):1786-1804. PubMed ID: 38434982
[TBL] [Abstract][Full Text] [Related]
16. Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2-Cre mice.
Hanna JA; Langdon CG; Garcia MR; Benton A; Lanman NA; Finkelstein D; Rehg JE; Hatley ME
J Pathol; 2022 May; 257(1):109-124. PubMed ID: 35066877
[TBL] [Abstract][Full Text] [Related]
17. Solitary Fibrous Tumor in the Perianal Region: Report of Two Cases With an Atypical Location.
Gonzalez JA; Sanchez E; Messa Botero O; Cervera-Bonilla S
Cureus; 2021 Jan; 13(1):e12887. PubMed ID: 33643733
[TBL] [Abstract][Full Text] [Related]
18. Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis.
Huangyang P; Li F; Lee P; Nissim I; Weljie AM; Mancuso A; Li B; Keith B; Yoon SS; Simon MC
Cell Metab; 2020 Jan; 31(1):174-188.e7. PubMed ID: 31761563
[TBL] [Abstract][Full Text] [Related]
19. Managing sarcoma: where have we come from and where are we going?
Bleloch JS; Ballim RD; Kimani S; Parkes J; Panieri E; Willmer T; Prince S
Ther Adv Med Oncol; 2017 Oct; 9(10):637-659. PubMed ID: 28974986
[TBL] [Abstract][Full Text] [Related]
20. Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
Borgatti A; Koopmeiners JS; Sarver AL; Winter AL; Stuebner K; Todhunter D; Rizzardi AE; Henriksen JC; Schmechel S; Forster CL; Kim JH; Froelich J; Walz J; Henson MS; Breen M; Lindblad-Toh K; Oh F; Pilbeam K; Modiano JF; Vallera DA
Mol Cancer Ther; 2017 May; 16(5):956-965. PubMed ID: 28193671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
